EWM
GSK icon

Executive Wealth Management’s GSK GSK Stock Holding History

Executive Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,235
Closed -$233K – 197
2021
Q4 		$233K Buy
+4,235
New +$220K 0.02% 178
2019
Q3 		– Sell
-240
Closed -$12K – 397
2019
Q2 		$12K Hold
240
– – ﹤0.01% 580
2019
Q1 		$13K Hold
240
– – ﹤0.01% 499
2018
Q4 		$11K Buy
+240
New +$11.8K ﹤0.01% 540

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Executive Wealth Management's GSK Position: Q1 2022 in Review

Executive Wealth Management sold out of GSK (GSK) in Q1 2022, closing a stake of 4,235 shares — an estimated $233K sold.

Executive Wealth Management first reported a position in GSK in Q4 2018 and held it in 4 quarters. The position peaked at $233K in Q4 2021. 929 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

  • Executive Wealth Management reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
  • Executive Wealth Management sold 4,235 GSK shares in Q1 2022, an estimated $233K.
  • Executive Wealth Management first reported a position in GSK in Q4 2018 and held it in 4 quarters.
  • Executive Wealth Management's GSK position peaked at $233K in Q4 2021.
  • 929 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on Executive Wealth Management's 13F filing for Q1 2022, filed 13 Apr 2022.